Header Logo

Connection

ADEL K EL-NAGGAR to Drug Antagonism

Back to Details
This is a "connection" page, showing publications ADEL K EL-NAGGAR has written about Drug Antagonism.
ADEL K EL-NAGGAR
Connection Strength
0.026
Drug Antagonism
  1. Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibody. Mol Cancer Ther. 2011 Dec; 10(12):2437-48.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.